SMNDC1

Across TCGA pan-cancer cohorts, SMNDC1 mass-spec protein differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of SMNDC1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where SMNDC1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types SMNDC1 is over-expressed in tumor.

COAD, HNSC, and LSCC are the cancer types where SMNDC1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SMNDC1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	III,IV	+0.432	<.001	12	view →
HNSC	Male	All	+0.376	<.001	11	view →
LSCC	Male	II,III,IV	+0.586	<.001	9	view →
LUAD	Male	All	+0.486	<.001	9	view →
CCRCC	Male	All	+0.098	<.001	6	view →
OV	All	All	+0.454	.002	2	view →
PDAC	All	All	+0.171	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

SMNDC1–COAD

Open the COAD breakdown →